Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / greenwich lifesciences trying to move a needle that

GLSI - Greenwich LifeSciences: Trying To Move A Needle That Doesn't Like To Budge

Greenwich LifeSciences Inc.

2024-06-26 13:45:17 ET

Summary

  • Greenwich LifeSciences, Inc. is a late-stage biotech company focusing on developing an immunotherapy treatment for breast cancer.
  • Their pipeline includes one drug, GLSI-100, currently in a phase 3 trial targeting breast cancer recurrence after surgery.
  • Financially, Greenwich LifeSciences has limited resources with a cash runway of approximately 2 quarters, making it a high-risk investment.

Topline Summary

For further details see:

Greenwich LifeSciences: Trying To Move A Needle That Doesn't Like To Budge
Stock Information
Company Name: Greenwich LifeSciences Inc.
Stock Symbol: GLSI
Market: NASDAQ
Website: greenwichlifesciences.com
Menu
GLSI GLSI Quote GLSI Short GLSI News GLSI Articles GLSI Message Board
Get GLSI Alerts

News, Short Squeeze, Breakout and More Instantly...